A controlled comparative study of clorprothixene vs. halopereidol in chronic schizophrenia

M. Fux; R. H. Belmaker

A controlled comparative study of clorprothixene vs. halopereidol in chronic schizophrenia

M. Fux, R. H. Belmaker

Medical School for International Health

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Neurochemical distinctions have been made between neuroleptic drugs that affect D-1 receptors as well as D-2 receptors, compared wih those neuroleptic drugs that affect only D-2 receptors. However, a controlled double-blind study of haloperidol vs. chlorprothixene in schizophrenic patients found no significant differences.

Original language	English
Pages (from-to)	37-40
Number of pages	4
Journal	Israel Journal of Psychiatry and Related Sciences
Volume	28
Issue number	1
State	Published - 1 Jan 1991

ASJC Scopus subject areas

Public Health, Environmental and Occupational Health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{a4ee82d2661a4bba86bc9c126f0a8e59,

title = "A controlled comparative study of clorprothixene vs. halopereidol in chronic schizophrenia",

abstract = "Neurochemical distinctions have been made between neuroleptic drugs that affect D-1 receptors as well as D-2 receptors, compared wih those neuroleptic drugs that affect only D-2 receptors. However, a controlled double-blind study of haloperidol vs. chlorprothixene in schizophrenic patients found no significant differences.",

author = "M. Fux and Belmaker, {R. H.}",

year = "1991",

month = jan,

day = "1",

language = "English",

volume = "28",

pages = "37--40",

journal = "Israel Journal of Psychiatry",

issn = "0333-7308",

publisher = "Mediafarm Group",

number = "1",

}

TY - JOUR

T1 - A controlled comparative study of clorprothixene vs. halopereidol in chronic schizophrenia

AU - Fux, M.

AU - Belmaker, R. H.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - Neurochemical distinctions have been made between neuroleptic drugs that affect D-1 receptors as well as D-2 receptors, compared wih those neuroleptic drugs that affect only D-2 receptors. However, a controlled double-blind study of haloperidol vs. chlorprothixene in schizophrenic patients found no significant differences.

AB - Neurochemical distinctions have been made between neuroleptic drugs that affect D-1 receptors as well as D-2 receptors, compared wih those neuroleptic drugs that affect only D-2 receptors. However, a controlled double-blind study of haloperidol vs. chlorprothixene in schizophrenic patients found no significant differences.

UR - http://www.scopus.com/inward/record.url?scp=0026058663&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0026058663

SN - 0333-7308

VL - 28

SP - 37

EP - 40

JO - Israel Journal of Psychiatry

JF - Israel Journal of Psychiatry

IS - 1

ER -

A controlled comparative study of clorprothixene vs. halopereidol in chronic schizophrenia

Abstract

ASJC Scopus subject areas

UN SDGs

Other files and links

Fingerprint

Cite this